Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Old West Investment Management Portfolio Manager | “Bruker makes high-end scientific instruments that let scientists study life and materials at the molecular level. Its products include mass spectrometry, magnetic resonance, X-ray, and microscopy systems used in life sciences, biopharma, diagnostics, and semiconductor manufacturing. Bruker was a detractor last quarter, but that reversed in Q2 after the company introduced new instrument platforms and pointed to growing semiconductor demand. Bank of America raised its price target from $49 to $65, and by late June the shares were near their 52-week high. In our view, Bruker's instruments are the tools that turn the physical world into data that AI can use, and the market is starting to see it that way too.” | NEUTRAL | Q2 2026 Aug 26, 2026 | View Pitch |
BBH Select Series - Mid Cap Fund Timothy F. Harris | “This scientific instruments provider is navigating temporary headwinds from delayed Chinese stimulus, a slow biopharma recovery, and potential academic funding cuts. However, its broad geographic diversification and exposure to varied non-government industrial and diagnostic end markets support its long-term resilience.” | BULL | Q1 2025 Mar 31, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
